-
Inserm 1037 - Cancer Research Center of Toulouse - University of Toulouse III | Toulouse, Midi Pyrenees | France | 3 months ago
4 Mar 2025 Job Information Organisation/Company Inserm 1037 - Cancer Research Center of Toulouse - University of Toulouse III Department Immunology Research Field Biological sciences » Biology
-
3 Mar 2025 Job Information Organisation/Company Inserm / CNRS / Nantes University Department CRCI2NA Research Field Biological sciences » Biology Researcher Profile Recognised Researcher (R2
-
14 Mar 2025 Job Information Organisation/Company INSERM Rhône Alpes Research Field Other Researcher Profile First Stage Researcher (R1) Positions Postdoc Positions Country France Application
-
7 Mar 2025 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1
-
and focusing performances, with the aim of getting down to a spot size of less than 50 µm for chemical imaging of biological tissues by mass spectrometry. Different strategies can be followed: 1
-
to a new research site (INSERM unit U1195 at Bicêtre hospital), where the research will take place. The candidate will benefit from state-of-the-art equipment in the fields of super-resolution imaging
-
position is available in the MINT laboratory of the University of Angers (UMR INSERM U1066 // UMR CNRS 6021) and this project will be developed in collaboration with MOLTECH-Anjou Laboratory
-
. The Laboratory of Physiology and Experimental Medicine of the Heart and Muscles (PhyMedExp) is a joint research unit (INSERM, CNRS, University of Montpellier). This multidisciplinary unit focuses on the physiology
-
team is part of the Centre Interdisciplinaire de Recherche en Biologie (Collège de France, CNRS, INSERM), located at the Collège de France in central Paris. The CIRB includes several cutting-edge
-
September 2025. We have recently shown the potential of dissolution DNP for metabolomics on a prototype instrument, and the new system will be key towards scaling up our hyperpolarized metabolomics workflow